Collecting blood samples from healthy volunteers for immune research
Blood Sampling of Healthy Volunteers for Immunological Research
This study is collecting blood samples from healthy volunteers to see how their immune cells compare to those of people with advanced cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 36 Years and up |
| Sex | All |
| Sponsor | The Netherlands Cancer Institute Academic / other |
| Locations | 1 site (Amsterdam) |
| Trial ID | NCT03819829 on ClinicalTrials.gov |
What this trial studies
This study aims to gather blood samples from healthy volunteers to analyze and characterize immune cells. Participants will donate five tubes of blood, which will be processed within 24 hours for comprehensive immune phenotyping. The goal is to establish a comparison between the immune profiles of healthy individuals and those of advanced cancer patients, using age-matched controls without a history of cancer or immunosuppressive medication.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy volunteers aged over 35 with no history of cancer.
Not a fit: Patients with a history of cancer or those currently using systemic immunosuppressive medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses in healthy individuals, aiding in the development of better treatments for cancer.
How similar studies have performed: Other studies have successfully utilized similar approaches to characterize immune responses, making this a well-supported methodology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age above 35 years * Written informed consent * No history of cancer * No use of systemic immunosuppressive medication (eg. corticosteroids). Local use of corticosteroids (eg. topical or inhalation) is allowed. Exclusion Criteria: * Fever 14 days before blood withdrawal * Donated blood for the same program within the last 2 years * Pregnancy
Where this trial is running
Amsterdam
- Nki-Avl — Amsterdam, Netherlands (Recruiting)
Study contacts
- Principal investigator: M Kok, MD — NKI-AvL
- Study coordinator: M Kok, MD
- Email: m.kok@nki.nl
- Phone: 3120512
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.